Michael P Lisanti

7PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersNaturopathyNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Protective Effects of N-Acetylcysteine Against Acrylamide-Induced Lung Toxicity via Regulation of GSK-3β/Nrf2/NF-κB Signaling: Molecular and Immunohistochemical Evidence.

|Nov 27, 2024
Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. Pharmaceuticals 2022, 15, 918.

Medhat Taha, Sara T Elazab, Alaa M Badawy

|Oct 27, 2023
Exploration of Tilmicosin Cardiotoxicity in Rats and the Protecting Role of the Rhodiola rosea Extract: Potential Roles of Cytokines, Antioxidant, Apoptotic, and Anti-Fibrotic Pathways.

Salwa A Elgendy, Mohamed Mohamed Soliman, Heba I Ghamry

|Jul 27, 2022
Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis.

Medhat Taha, Sara T Elazab, Alaa M Badawy

|Jun 27, 2020
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production.

Marco Fiorillo, Fanni Tóth, Matteo Brindisi

|May 30, 2020
Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells.

Hend M Nawara, Said M Afify, Ghmkin Hassan

Pageof 2

Frequent Collaborators

2 joint publications

Said M Afify

2 joint publications

Ghmkin Hassan

2 joint publications

Masaharu Seno

2 joint publications

Medhat Taha